HST Global Logo   Home | FAQ | News
header people

 

 

 

May 21, 2013

HST Global releases 10-Q 1Q2013 XBRL Files

Click here to download.

 

March 1, 2012

HST Global seeking partners for Distribution and Marketing

Ronald R. Howell, CEO is pleased to announce that he is looking for emerging partners for distribution and marketing of products integrating Raspberry Keytone as the primary ingredient in their delivery system.  This strategy builds on the Company’s experience of developing integrative products that provide foundational contributions to health at the cellular level.  This opportunity further builds on the Company’s philosophy of building a protocol that will work within the body to address current challenges while at the same time work as a preventive product to provide the immune system “core” ingredients necessary to maintain optimum health.  He states "We are excited to initiate conversations with high profile companies in the health industry in our effort to distribute our Raspberry Heat product.  Many individuals will experience the benefits this product contributes to their well-being.”

 

June 1, 2010

HST Global Executes Agreement for the Acquisition of First Wellness Center

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC) today announced it has entered into a formal agreement which outlines the deal points associated with the acquisition of its first Wellness Center located in Reno, Nevada.

This pending acquisition is a part of the evolution of HST’s development of a global presence in the emerging immunotherapy treatment of cancer.

Ron Howell, President and CEO of HST Global, Inc. stated, “HST is excited to have completed the initial due diligence to move forward with the final documentation necessary for this acquisition. The execution of the Acquisition Agreement for the proven FIT technology is a significant step in our strategic global expansion plans.”

Read the full news release on BusinessWire.com

May 4, 2010

HST Global Announces Details of Protocol Licensing for Health Matters International

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC) today announced that it has formalized the licensing details for Health Matters International.

As previously announced, HST Global Inc. (HST) has partnered with Health Matters International (HMI), a Canadian Company that has vast international knowledge in the Healthcare Industry. Through this association, HMI identified Panama and Costa Rica as potential countries for the development of HST's Clinical Treatment Facilities which features the company's "FIT" protocol.

HMI focuses on providing a solution to the rising cost of prescription medications and other health care related matters. They pride themselves on ensuring safe, high quality and low cost prescription medications through their Canadian and International Pharmacies. Headquartered in Calgary, Alberta with pharmacies in New Zealand, Italy, India, USA and Canada they employ a safe, high quality and low cost methodology for delivery of prescription medication.

Read the full news release on BusinessWire.com

April 30, 2010

HST Global, Inc. Encouraged by FDA Approval of Dendreonís Provenge

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC) today was encouraged by news of the FDA approval of Dendreon Corp's (NASDAQ: DNDN) Provenge drug for prostate cancer. Provenge is aimed at certain men with advanced prostate cancer and uses a man's own immune system to fight the disease.

Dr. Mitchell Gold, CEO and President of Dendreon stated "The FDA approval of Provenge is a testament to the courage of the patients and researchers who participated in our studies and is the culmination of nearly 15 years of research and development by our dedicated employees."

Ron Howell, President and CEO stated "We congratulate Dendreon Corp on receiving the approval from the FDA, as this is a testament to the perseverance and dedication of their entire corporate team. We are encouraged by the FDA's action in approving Provenge. HST is committed to the acquisition and development of Health and Wellness Centers offering proven alternative and immunotherapy drug candidates that have shown high efficacy in the treatment of various cancers."

Read the full news release on BusinessWire.com

April 29, 2010

HST Global Announces Formalization of Protocol Licensing for International Partnerships

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC) today announced that it has finalized the formal licensing model that will be used by our international partners in the development of our Clinical Treatment Facilities worldwide.

As previously announced, HST Global Inc. (HST) has partnered with Health Matters International (HMI), a Canadian Company that has vast international knowledge in the Healthcare Industry. Through this association, HMI identified Panama and Costa Rica as potential countries for the development of HSTís Clinical Treatment Facilities which features the companyís "FIT" protocol. Doctors that will have a role as part of the initial medical team in these clinics recently visited the prototype facility in Reno.

Licensing fees will range between $250,000 and $500,000 and will be measured against the "drawing" population of the location. While other factors will be involved in each individual country such as demographic data and economic circumstances, the fee will incorporate training, initial products and onsite development for each respective team. In addition, HST will be paid a royalty amount for each application of the Company's protocol.

Read the full news release on BusinessWire.com

April 27, 2010

HST Global Announces Strategic Partner for Panamanian Facility Also Desires to Open Facility in Costa Rica

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC) today announced that the global partner previously identified for the possible development of a Clinical Treatment Facility in Panama has also expressed a desire to open a Clinical Treatment Facility in Costa Rica.

HST Global is partnering with Greg Benson, President and CEO of Health Matters International, a Canadian Company. Greg and his company bring immense international knowledge in the Healthcare industry inside and outside the United States, specifically with influence in Central and South America. With Greg's assistance, the Company intends to License the "FIT" protocol, as well as other pending protocols, to Clinical Treatment Facilities in both Panama and Costa Rica.

Greg Benson, President and CEO of Health Matters International, stated, "Ron and his team at HST Global are dedicated to bringing humanity alternative treatments for life threatening illnesses, specifically late stage cancer. HST Global is relying on international markets to gain a universal "footprint" and reach a worldwide audience. During communications with HST, it became apparent there were synergies between our companies that could be employed to develop Clinical Treatment Facilities in both Panama and Costa Rica."

Read the full news release on BusinessWire.com

March 17, 2010

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)

HST Global, Inc. today announced that it is in final negotiations to obtain the needed capital to complete the acquisition of its first wellness center. This infusion of cash will allow HST to complete the wellness center acquisition and provide operating capital.

Financing will be in the form of a $2,000,000 non-convertible debenture. HST promises to pay to the registered holder the aggregate principal face sum Twenty-Four (24) months from the date of issuance, and to pay interest on the principal sum outstanding, at the rate of 12% per annum commencing upon the first business day following the 6 month anniversary of the closing and such semi-annual periods thereafter.

Wesley Tate, CFO of HST Global, Inc. stated, "We are encouraged by the progress of these negotiations and believe they will conclude in the near future. We anticipate annual gross revenues for each individual clinic of approximately between 8 and 10 million dollars per year. More importantly, this will permit the funding of this acquisition without diluting our current shareholderís equity while substantiating shareholder value."

Read the full news release on BusinessWire.com

March 9, 2010

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)

HST Global, Inc. today announced that Dr. James Forsythe, MD, HMD, is experiencing continuous success with his Forsythe Immune Therapy (FIT) Protocol. Dr. James Forsythe, MD, HMD, is a board certified oncologist and a member of HST Global Inc.ís Board of Directors and Scientific Advisory Board.

Dr. Forsytheís existing study is meeting with 70-80% efficacy in clinical treatment of Stage IV cancers in a test of 450 patients. The highlight of the study is in stage IV prostate cancer where they have met with 86% efficacy with prostate cancer patients over 55 months through the application of his "FIT" Protocol.

Ronald Howell President and CEO of HST Global, Inc. stated, "We are encouraged by the continued success Dr. Forsythe is experiencing with his FIT protocol. The updated study results demonstrate the efficacy of the FIT Protocol."

Read the full news release on BusinessWire.com

February 16, 2010

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)

HST Global, Inc. today announced that it has entered into a formal marketing agreement with Dr. James Forsythe, MD, HMD, board certified oncologist and a member of HST Global Inc.ís Board of Directors and Scientific Advisory Board.

According to the agreement, Dr. Forsythe and HST Global will be working together to manufacture, market and sell Dr. Forsytheís Technologies under the trademark "FIT". HST Global will be allowed to employ Dr. Forsytheís image, expertise and related intellectual property. HST Global has acquired an exclusive license to manufacture, market and sell these products throughout the world and has obtained the exclusive right to use Dr. Forsytheís identification and endorsement in connection with the marketing, sale and distribution of the FIT Technology Products.

Mr. Ron Howell, CEO and President of HST Global, Inc., stated, "This agreement significantly expands the relationship developed with Dr. Forsythe over the past two years. The company is poised to experience growth in 2010 through our current Wellness Clinic development strategies in Ecuador and Panama coupled with the marketing and sales of our line of nutraceutical products. The company continues to place emphasis on efforts to provide a growing world population with alternative integrative science-based products and treatments."

Read the full news release on BusinessWire.com

February 8, 2010

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)

HST Global, Inc. today announced that it has identified a global partner for the possible development of a Clinical Treatment Facility in Panama.

This information, coupled with the recent announcement pertaining to the Ecuadorian Treatment Facility, further signifies HST Globalís commitment to develop Cancer Treatment Centers worldwide. As previously stated, HST Global is relying on international markets to reach a worldwide audience. The Company is continually being presented with opportunities to bring its integrative science-based cancer treatment protocols to a global population.

Mr. Ron Howell, CEO and President of HST Global, Inc., stated, "At HST, we continue to take advantage of the relationships we have groomed over the past year. The fact we have partners that are familiar with the demographic idiosyncrasies, economic conditions and political climate of a particular region is invaluable during the initial stages of developing a facility. Through this partnership, we will be able to exploit this indigenous knowledge as well as leverage and align our resources in an effort to develop our Panamanian Treatment Facility."

Read the full news release on BusinessWire.com

February 2, 2010

HAMPTON, Va.--(BUSINESS WIRE)--HST Global, Inc. (OTCBB:HSTC)

HST Global, Inc. today announced that it has targeted Ecuador for development of a Clinical Treatment Facility.

As the acceptance of integrative science-based cancer treatments worldwide continues to grow, so has HST Global, Inc.ís strategy of opening our own brand of Cancer Treatment Centers. To further facilitate this approach, HST Global is relying on international markets to reach a worldwide population. HST feels Ecuador will provide a significant platform to benefit patients on a global scale.

Mr. Ron Howell, CEO and President of HST Global Inc., stated, "We are impressed with the demographic diversity and economic infrastructure that Ecuador has developed. They have built world-class facilities that offer cutting edge technologies that complement our clinical protocols. We are in the initial phases of developing our entry strategy for Ecuador through relationships we have developed worldwide. These global partners will allow HST to leverage itself and align its resources in an effort to develop an Ecuadorian facility."

Read the full news release on BusinessWire.com

Older News

Read news from 2009.

Copyright © 2010 HST Global - Adding Life to your Years.